NewAmsterdam Pharma Company N.V.

NAMS · NASDAQ
Analyze with AI
$34.22−$1.13 (−3.2%)
At close:Dec 16, 2025, 9:00 PM UTC
$34.58+$0.36 (+1.05%)
After hours:Dec 17, 2025, 1:40 PM UTC
P/E TTM-18.42
P/B TTM5.59
P/S TTM110.03
Dividend Yield0%
EPS-$2.04
Beta0.053
Valuation
PEG Ratio0.71
FCF Yield-3.73%
EV / EBITDA-11.59
Quality
ROIC-27.86%
Gross Margin99.82%
Cash Conv. Ratio1.57
Growth
Revenue 3Y CAGR-23.73%
FCF Growth-12.74%
Safety
Net Debt / EBITDA1.87
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-11,952.49

NewAmsterdam Pharma Company N.V. (NAMS) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is NewAmsterdam Pharma Company N.V. (NAMS) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, NewAmsterdam Pharma Company N.V. (NAMS) stock is trading at $34.22. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NAMS stock quotes for informed trading decisions.

What is NewAmsterdam Pharma Company N.V.'s market capitalization?

NewAmsterdam Pharma Company N.V. (NAMS) has a market capitalization of approximately $3.9B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare NewAmsterdam Pharma Company N.V.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NAMS stock price changes.

What is the 52-week range for NewAmsterdam Pharma Company N.V. stock?

NewAmsterdam Pharma Company N.V. (NAMS) stock has traded in a 52-week range of $14.06 — $42.00. The 52-week range shows the highest and lowest prices at which NAMS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current NewAmsterdam Pharma Company N.V. stock price to this range provides context for recent price action.

How much trading volume does NewAmsterdam Pharma Company N.V. stock have?

NewAmsterdam Pharma Company N.V. (NAMS) stock recently traded approximately 987.7K shares. Trading volume indicates market liquidity and investor interest in NAMS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting NewAmsterdam Pharma Company N.V. stock.

Does NewAmsterdam Pharma Company N.V. pay dividends to shareholders?

Yes, NewAmsterdam Pharma Company N.V. (NAMS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate NewAmsterdam Pharma Company N.V. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is NewAmsterdam Pharma Company N.V.'s intraday price range?

Today, NewAmsterdam Pharma Company N.V. (NAMS) stock has traded in a range of $34.22 — $35.92. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NAMS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get NewAmsterdam Pharma Company N.V. stock data?

AlphaPilot sources real-time NAMS stock quotes, fundamental financial data, and historical price charts for NewAmsterdam Pharma Company N.V. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The NewAmsterdam Pharma Company N.V. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NAMS stock performance.